Climb Bio, INC. 8-K Filing
Ticker: CLYM · Form: 8-K · Filed: Dec 31, 2025 · CIK: 1768446
Sentiment: neutral
Filing Stats: 539 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-12-31 16:12:49
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share CLYM The Nasdaq Stock Mar
Filing Documents
- d19559d8k.htm (8-K) — 26KB
- d19559dex991.htm (EX-99.1) — 48KB
- 0001193125-25-338318.txt ( ) — 202KB
- clym-20251231.xsd (EX-101.SCH) — 3KB
- clym-20251231_lab.xml (EX-101.LAB) — 18KB
- clym-20251231_pre.xml (EX-101.PRE) — 11KB
- d19559d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Complaint, dated December 31, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Climb Bio, Inc. Date: December 31, 2025 By: /s/ Aoife Brennan Aoife Brennan, M.B., Ch.B. President and Chief Executive Officer